The a2 Milk Company Limited
The a2 Milk Company Limited (ACOPF) Stock Competitors & Peer Comparison
See (ACOPF) competitors and their performances in Stock Market.
Peer Comparison Table: Packaged Foods Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACOPF | $6.75 | +0.00% | 4.7B | 38.44 | $0.17 | +2.07% |
| NSRGY | $104.68 | -0.04% | 268.2B | 20.08 | $5.19 | +3.26% |
| NSRGF | $104.76 | -0.75% | 266B | 19.92 | $5.19 | +3.57% |
| DANOY | $17.05 | -1.96% | 55.8B | 25.49 | $0.68 | +2.72% |
| GPDNF | $85.82 | +0.00% | 55B | 25.35 | $3.36 | +2.86% |
| JBSAY | $13.81 | +3.06% | 30.6B | 6.94 | $1.99 | +7.26% |
| AJINF | $30.00 | +9.21% | 28.8B | 125.00 | $0.24 | +0.99% |
| ASBFF | $28.38 | +0.00% | 20B | 14.70 | $1.93 | +2.98% |
| ASBFY | $26.41 | -0.68% | 18.8B | 13.70 | $1.93 | +2.86% |
| JDEPF | $36.40 | -0.01% | 17.7B | 25.11 | $1.45 | +2.35% |
Stock Comparison
ACOPF vs NSRGY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NSRGY has a market cap of 268.2B. Regarding current trading prices, ACOPF is priced at $6.75, while NSRGY trades at $104.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NSRGY's P/E ratio is 20.08. In terms of profitability, ACOPF's ROE is +0.16%, compared to NSRGY's ROE of +0.29%. Regarding short-term risk, ACOPF is less volatile compared to NSRGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NSRGY's competition here
ACOPF vs NSRGF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NSRGF has a market cap of 266B. Regarding current trading prices, ACOPF is priced at $6.75, while NSRGF trades at $104.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NSRGF's P/E ratio is 19.92. In terms of profitability, ACOPF's ROE is +0.16%, compared to NSRGF's ROE of +0.29%. Regarding short-term risk, ACOPF is less volatile compared to NSRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NSRGF's competition here
ACOPF vs DANOY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, DANOY has a market cap of 55.8B. Regarding current trading prices, ACOPF is priced at $6.75, while DANOY trades at $17.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas DANOY's P/E ratio is 25.49. In terms of profitability, ACOPF's ROE is +0.16%, compared to DANOY's ROE of +0.11%. Regarding short-term risk, ACOPF is less volatile compared to DANOY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check DANOY's competition here
ACOPF vs GPDNF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GPDNF has a market cap of 55B. Regarding current trading prices, ACOPF is priced at $6.75, while GPDNF trades at $85.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GPDNF's P/E ratio is 25.35. In terms of profitability, ACOPF's ROE is +0.16%, compared to GPDNF's ROE of +0.11%. Regarding short-term risk, ACOPF and GPDNF have similar daily volatility (0.00).Check GPDNF's competition here
ACOPF vs JBSAY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, JBSAY has a market cap of 30.6B. Regarding current trading prices, ACOPF is priced at $6.75, while JBSAY trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas JBSAY's P/E ratio is 6.94. In terms of profitability, ACOPF's ROE is +0.16%, compared to JBSAY's ROE of +0.29%. Regarding short-term risk, ACOPF is less volatile compared to JBSAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check JBSAY's competition here
ACOPF vs AJINF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, AJINF has a market cap of 28.8B. Regarding current trading prices, ACOPF is priced at $6.75, while AJINF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas AJINF's P/E ratio is 125.00. In terms of profitability, ACOPF's ROE is +0.16%, compared to AJINF's ROE of +0.11%. Regarding short-term risk, ACOPF and AJINF have similar daily volatility (0.00).Check AJINF's competition here
ACOPF vs ASBFF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, ASBFF has a market cap of 20B. Regarding current trading prices, ACOPF is priced at $6.75, while ASBFF trades at $28.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas ASBFF's P/E ratio is 14.70. In terms of profitability, ACOPF's ROE is +0.16%, compared to ASBFF's ROE of +0.08%. Regarding short-term risk, ACOPF and ASBFF have similar daily volatility (0.00).Check ASBFF's competition here
ACOPF vs ASBFY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, ASBFY has a market cap of 18.8B. Regarding current trading prices, ACOPF is priced at $6.75, while ASBFY trades at $26.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas ASBFY's P/E ratio is 13.70. In terms of profitability, ACOPF's ROE is +0.16%, compared to ASBFY's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to ASBFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check ASBFY's competition here
ACOPF vs JDEPF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, JDEPF has a market cap of 17.7B. Regarding current trading prices, ACOPF is priced at $6.75, while JDEPF trades at $36.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas JDEPF's P/E ratio is 25.11. In terms of profitability, ACOPF's ROE is +0.16%, compared to JDEPF's ROE of +0.06%. Regarding short-term risk, ACOPF and JDEPF have similar daily volatility (0.00).Check JDEPF's competition here
ACOPF vs GRBMF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GRBMF has a market cap of 17.2B. Regarding current trading prices, ACOPF is priced at $6.75, while GRBMF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GRBMF's P/E ratio is 26.67. In terms of profitability, ACOPF's ROE is +0.16%, compared to GRBMF's ROE of +0.09%. Regarding short-term risk, ACOPF and GRBMF have similar daily volatility (0.00).Check GRBMF's competition here
ACOPF vs WHGLY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, WHGLY has a market cap of 16.4B. Regarding current trading prices, ACOPF is priced at $6.75, while WHGLY trades at $25.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas WHGLY's P/E ratio is 10.14. In terms of profitability, ACOPF's ROE is +0.16%, compared to WHGLY's ROE of +0.15%. Regarding short-term risk, ACOPF is less volatile compared to WHGLY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check WHGLY's competition here
ACOPF vs BMBOY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, BMBOY has a market cap of 16.3B. Regarding current trading prices, ACOPF is priced at $6.75, while BMBOY trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas BMBOY's P/E ratio is 24.80. In terms of profitability, ACOPF's ROE is +0.16%, compared to BMBOY's ROE of +0.09%. Regarding short-term risk, ACOPF and BMBOY have similar daily volatility (0.00).Check BMBOY's competition here
ACOPF vs AJINY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, AJINY has a market cap of 15.2B. Regarding current trading prices, ACOPF is priced at $6.75, while AJINY trades at $29.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas AJINY's P/E ratio is 118.89. In terms of profitability, ACOPF's ROE is +0.16%, compared to AJINY's ROE of +0.11%. Regarding short-term risk, ACOPF is less volatile compared to AJINY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check AJINY's competition here
ACOPF vs WHGRF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, WHGRF has a market cap of 14.8B. Regarding current trading prices, ACOPF is priced at $6.75, while WHGRF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas WHGRF's P/E ratio is 8.85. In terms of profitability, ACOPF's ROE is +0.16%, compared to WHGRF's ROE of +0.15%. Regarding short-term risk, ACOPF and WHGRF have similar daily volatility (0.00).Check WHGRF's competition here
ACOPF vs KRYAY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, KRYAY has a market cap of 13.8B. Regarding current trading prices, ACOPF is priced at $6.75, while KRYAY trades at $86.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas KRYAY's P/E ratio is 17.39. In terms of profitability, ACOPF's ROE is +0.16%, compared to KRYAY's ROE of +0.11%. Regarding short-term risk, ACOPF is less volatile compared to KRYAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check KRYAY's competition here
ACOPF vs KRYAF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, KRYAF has a market cap of 13.5B. Regarding current trading prices, ACOPF is priced at $6.75, while KRYAF trades at $84.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas KRYAF's P/E ratio is 17.10. In terms of profitability, ACOPF's ROE is +0.16%, compared to KRYAF's ROE of +0.09%. Regarding short-term risk, ACOPF and KRYAF have similar daily volatility (0.00).Check KRYAF's competition here
ACOPF vs ORKLF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, ORKLF has a market cap of 13.5B. Regarding current trading prices, ACOPF is priced at $6.75, while ORKLF trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas ORKLF's P/E ratio is 20.22. In terms of profitability, ACOPF's ROE is +0.16%, compared to ORKLF's ROE of +0.24%. Regarding short-term risk, ACOPF and ORKLF have similar daily volatility (0.00).Check ORKLF's competition here
ACOPF vs ORKLY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, ORKLY has a market cap of 13.3B. Regarding current trading prices, ACOPF is priced at $6.75, while ORKLY trades at $13.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas ORKLY's P/E ratio is 19.90. In terms of profitability, ACOPF's ROE is +0.16%, compared to ORKLY's ROE of +0.24%. Regarding short-term risk, ACOPF is less volatile compared to ORKLY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check ORKLY's competition here
ACOPF vs SAPIF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, SAPIF has a market cap of 12.4B. Regarding current trading prices, ACOPF is priced at $6.75, while SAPIF trades at $31.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas SAPIF's P/E ratio is 26.69. In terms of profitability, ACOPF's ROE is +0.16%, compared to SAPIF's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to SAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check SAPIF's competition here
ACOPF vs SDPNF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, SDPNF has a market cap of 10.3B. Regarding current trading prices, ACOPF is priced at $6.75, while SDPNF trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas SDPNF's P/E ratio is 14.89. In terms of profitability, ACOPF's ROE is +0.16%, compared to SDPNF's ROE of +0.14%. Regarding short-term risk, ACOPF is less volatile compared to SDPNF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check SDPNF's competition here
ACOPF vs BRZL Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, BRZL has a market cap of 10.1B. Regarding current trading prices, ACOPF is priced at $6.75, while BRZL trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas BRZL's P/E ratio is N/A. In terms of profitability, ACOPF's ROE is +0.16%, compared to BRZL's ROE of +0.91%. Regarding short-term risk, ACOPF is less volatile compared to BRZL. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check BRZL's competition here
ACOPF vs LOTBY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, LOTBY has a market cap of 9.8B. Regarding current trading prices, ACOPF is priced at $6.75, while LOTBY trades at $120.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas LOTBY's P/E ratio is 51.92. In terms of profitability, ACOPF's ROE is +0.16%, compared to LOTBY's ROE of +0.21%. Regarding short-term risk, ACOPF and LOTBY have similar daily volatility (0.00).Check LOTBY's competition here
ACOPF vs TYCMY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TYCMY has a market cap of 9.5B. Regarding current trading prices, ACOPF is priced at $6.75, while TYCMY trades at $33.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TYCMY's P/E ratio is 15.95. In terms of profitability, ACOPF's ROE is +0.16%, compared to TYCMY's ROE of +0.31%. Regarding short-term risk, ACOPF is less volatile compared to TYCMY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TYCMY's competition here
ACOPF vs KIKOY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, KIKOY has a market cap of 9B. Regarding current trading prices, ACOPF is priced at $6.75, while KIKOY trades at $19.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas KIKOY's P/E ratio is 24.45. In terms of profitability, ACOPF's ROE is +0.16%, compared to KIKOY's ROE of +0.12%. Regarding short-term risk, ACOPF and KIKOY have similar daily volatility (0.00).Check KIKOY's competition here
ACOPF vs TTAZF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TTAZF has a market cap of 8.8B. Regarding current trading prices, ACOPF is priced at $6.75, while TTAZF trades at $7.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TTAZF's P/E ratio is 77.60. In terms of profitability, ACOPF's ROE is +0.16%, compared to TTAZF's ROE of N/A. Regarding short-term risk, ACOPF and TTAZF have similar daily volatility (0.00).Check TTAZF's competition here
ACOPF vs CIADF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, CIADF has a market cap of 8.5B. Regarding current trading prices, ACOPF is priced at $6.75, while CIADF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas CIADF's P/E ratio is -220.00. In terms of profitability, ACOPF's ROE is +0.16%, compared to CIADF's ROE of -0.01%. Regarding short-term risk, ACOPF and CIADF have similar daily volatility (0.00).Check CIADF's competition here
ACOPF vs CIADY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, CIADY has a market cap of 8.4B. Regarding current trading prices, ACOPF is priced at $6.75, while CIADY trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas CIADY's P/E ratio is -194.27. In terms of profitability, ACOPF's ROE is +0.16%, compared to CIADY's ROE of -0.01%. Regarding short-term risk, ACOPF is less volatile compared to CIADY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check CIADY's competition here
ACOPF vs KIKOF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, KIKOF has a market cap of 8.2B. Regarding current trading prices, ACOPF is priced at $6.75, while KIKOF trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas KIKOF's P/E ratio is 22.56. In terms of profitability, ACOPF's ROE is +0.16%, compared to KIKOF's ROE of +0.11%. Regarding short-term risk, ACOPF and KIKOF have similar daily volatility (0.00).Check KIKOF's competition here
ACOPF vs WWNTY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, WWNTY has a market cap of 7.5B. Regarding current trading prices, ACOPF is priced at $6.75, while WWNTY trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas WWNTY's P/E ratio is 12.35. In terms of profitability, ACOPF's ROE is +0.16%, compared to WWNTY's ROE of +0.30%. Regarding short-term risk, ACOPF and WWNTY have similar daily volatility (0.00).Check WWNTY's competition here
ACOPF vs TSUKY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TSUKY has a market cap of 7.4B. Regarding current trading prices, ACOPF is priced at $6.75, while TSUKY trades at $77.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TSUKY's P/E ratio is 18.46. In terms of profitability, ACOPF's ROE is +0.16%, compared to TSUKY's ROE of +0.13%. Regarding short-term risk, ACOPF is less volatile compared to TSUKY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TSUKY's competition here
ACOPF vs TCYMF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TCYMF has a market cap of 7.3B. Regarding current trading prices, ACOPF is priced at $6.75, while TCYMF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TCYMF's P/E ratio is 13.00. In terms of profitability, ACOPF's ROE is +0.16%, compared to TCYMF's ROE of +0.31%. Regarding short-term risk, ACOPF and TCYMF have similar daily volatility (0.00).Check TCYMF's competition here
ACOPF vs ARHUF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, ARHUF has a market cap of 7.3B. Regarding current trading prices, ACOPF is priced at $6.75, while ARHUF trades at $27.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas ARHUF's P/E ratio is 19.16. In terms of profitability, ACOPF's ROE is +0.16%, compared to ARHUF's ROE of +0.18%. Regarding short-term risk, ACOPF and ARHUF have similar daily volatility (0.00).Check ARHUF's competition here
ACOPF vs TSUKF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TSUKF has a market cap of 6.9B. Regarding current trading prices, ACOPF is priced at $6.75, while TSUKF trades at $70.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TSUKF's P/E ratio is 17.59. In terms of profitability, ACOPF's ROE is +0.16%, compared to TSUKF's ROE of +0.13%. Regarding short-term risk, ACOPF and TSUKF have similar daily volatility (0.00).Check TSUKF's competition here
ACOPF vs MEJHY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, MEJHY has a market cap of 6.8B. Regarding current trading prices, ACOPF is priced at $6.75, while MEJHY trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas MEJHY's P/E ratio is 23.15. In terms of profitability, ACOPF's ROE is +0.16%, compared to MEJHY's ROE of +0.06%. Regarding short-term risk, ACOPF and MEJHY have similar daily volatility (0.00).Check MEJHY's competition here
ACOPF vs WWNTF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, WWNTF has a market cap of 6.6B. Regarding current trading prices, ACOPF is priced at $6.75, while WWNTF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas WWNTF's P/E ratio is 11.20. In terms of profitability, ACOPF's ROE is +0.16%, compared to WWNTF's ROE of +0.30%. Regarding short-term risk, ACOPF and WWNTF have similar daily volatility (0.00).Check WWNTF's competition here
ACOPF vs DLLFF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, DLLFF has a market cap of 6.5B. Regarding current trading prices, ACOPF is priced at $6.75, while DLLFF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas DLLFF's P/E ratio is 14.00. In terms of profitability, ACOPF's ROE is +0.16%, compared to DLLFF's ROE of N/A. Regarding short-term risk, ACOPF and DLLFF have similar daily volatility (0.00).Check DLLFF's competition here
ACOPF vs GPAGF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GPAGF has a market cap of 6.5B. Regarding current trading prices, ACOPF is priced at $6.75, while GPAGF trades at $18.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GPAGF's P/E ratio is 12.05. In terms of profitability, ACOPF's ROE is +0.16%, compared to GPAGF's ROE of +0.23%. Regarding short-term risk, ACOPF and GPAGF have similar daily volatility (0.00).Check GPAGF's competition here
ACOPF vs GCHOY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GCHOY has a market cap of 6.5B. Regarding current trading prices, ACOPF is priced at $6.75, while GCHOY trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GCHOY's P/E ratio is 27.31. In terms of profitability, ACOPF's ROE is +0.16%, compared to GCHOY's ROE of +0.16%. Regarding short-term risk, ACOPF is less volatile compared to GCHOY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check GCHOY's competition here
ACOPF vs NFPDF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NFPDF has a market cap of 6.3B. Regarding current trading prices, ACOPF is priced at $6.75, while NFPDF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NFPDF's P/E ratio is 20.39. In terms of profitability, ACOPF's ROE is +0.16%, compared to NFPDF's ROE of +0.14%. Regarding short-term risk, ACOPF and NFPDF have similar daily volatility (0.00).Check NFPDF's competition here
ACOPF vs MEJHF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, MEJHF has a market cap of 6.2B. Regarding current trading prices, ACOPF is priced at $6.75, while MEJHF trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas MEJHF's P/E ratio is 19.34. In terms of profitability, ACOPF's ROE is +0.16%, compared to MEJHF's ROE of +0.06%. Regarding short-term risk, ACOPF is less volatile compared to MEJHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check MEJHF's competition here
ACOPF vs SGLJF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, SGLJF has a market cap of 6.2B. Regarding current trading prices, ACOPF is priced at $6.75, while SGLJF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas SGLJF's P/E ratio is 22.58. In terms of profitability, ACOPF's ROE is +0.16%, compared to SGLJF's ROE of +0.21%. Regarding short-term risk, ACOPF and SGLJF have similar daily volatility (0.00).Check SGLJF's competition here
ACOPF vs PIFFY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, PIFFY has a market cap of 5.7B. Regarding current trading prices, ACOPF is priced at $6.75, while PIFFY trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas PIFFY's P/E ratio is 16.15. In terms of profitability, ACOPF's ROE is +0.16%, compared to PIFFY's ROE of +0.13%. Regarding short-term risk, ACOPF and PIFFY have similar daily volatility (0.00).Check PIFFY's competition here
ACOPF vs SMPFF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, SMPFF has a market cap of 5.2B. Regarding current trading prices, ACOPF is priced at $6.75, while SMPFF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas SMPFF's P/E ratio is 13.38. In terms of profitability, ACOPF's ROE is +0.16%, compared to SMPFF's ROE of +0.24%. Regarding short-term risk, ACOPF and SMPFF have similar daily volatility (0.00).Check SMPFF's competition here
ACOPF vs EMLZF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, EMLZF has a market cap of 5.2B. Regarding current trading prices, ACOPF is priced at $6.75, while EMLZF trades at $969.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas EMLZF's P/E ratio is 18.94. In terms of profitability, ACOPF's ROE is +0.16%, compared to EMLZF's ROE of +0.22%. Regarding short-term risk, ACOPF and EMLZF have similar daily volatility (0.00).Check EMLZF's competition here
ACOPF vs TATYY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TATYY has a market cap of 5.1B. Regarding current trading prices, ACOPF is priced at $6.75, while TATYY trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TATYY's P/E ratio is 59.31. In terms of profitability, ACOPF's ROE is +0.16%, compared to TATYY's ROE of +0.02%. Regarding short-term risk, ACOPF is less volatile compared to TATYY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TATYY's competition here
ACOPF vs GLAPY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GLAPY has a market cap of 5B. Regarding current trading prices, ACOPF is priced at $6.75, while GLAPY trades at $99.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GLAPY's P/E ratio is 41.06. In terms of profitability, ACOPF's ROE is +0.16%, compared to GLAPY's ROE of +0.06%. Regarding short-term risk, ACOPF and GLAPY have similar daily volatility (0.00).Check GLAPY's competition here
ACOPF vs GLAPF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GLAPF has a market cap of 4.8B. Regarding current trading prices, ACOPF is priced at $6.75, while GLAPF trades at $19.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GLAPF's P/E ratio is 42.53. In terms of profitability, ACOPF's ROE is +0.16%, compared to GLAPF's ROE of +0.09%. Regarding short-term risk, ACOPF and GLAPF have similar daily volatility (0.00).Check GLAPF's competition here
ACOPF vs IOIOF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, IOIOF has a market cap of 4.8B. Regarding current trading prices, ACOPF is priced at $6.75, while IOIOF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas IOIOF's P/E ratio is 12.64. In terms of profitability, ACOPF's ROE is +0.16%, compared to IOIOF's ROE of +0.10%. Regarding short-term risk, ACOPF and IOIOF have similar daily volatility (0.00).Check IOIOF's competition here
ACOPF vs CHFLF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, CHFLF has a market cap of 4.5B. Regarding current trading prices, ACOPF is priced at $6.75, while CHFLF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas CHFLF's P/E ratio is 12.38. In terms of profitability, ACOPF's ROE is +0.16%, compared to CHFLF's ROE of +0.10%. Regarding short-term risk, ACOPF and CHFLF have similar daily volatility (0.00).Check CHFLF's competition here
ACOPF vs PIFMF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, PIFMF has a market cap of 4.4B. Regarding current trading prices, ACOPF is priced at $6.75, while PIFMF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas PIFMF's P/E ratio is 10.00. In terms of profitability, ACOPF's ROE is +0.16%, compared to PIFMF's ROE of +0.11%. Regarding short-term risk, ACOPF and PIFMF have similar daily volatility (0.00).Check PIFMF's competition here
ACOPF vs NHFOF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NHFOF has a market cap of 4.3B. Regarding current trading prices, ACOPF is priced at $6.75, while NHFOF trades at $44.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NHFOF's P/E ratio is 25.28. In terms of profitability, ACOPF's ROE is +0.16%, compared to NHFOF's ROE of +0.06%. Regarding short-term risk, ACOPF and NHFOF have similar daily volatility (0.00).Check NHFOF's competition here
ACOPF vs CFEIY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, CFEIY has a market cap of 4.2B. Regarding current trading prices, ACOPF is priced at $6.75, while CFEIY trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas CFEIY's P/E ratio is 11.10. In terms of profitability, ACOPF's ROE is +0.16%, compared to CFEIY's ROE of +0.10%. Regarding short-term risk, ACOPF and CFEIY have similar daily volatility (0.00).Check CFEIY's competition here
ACOPF vs NIPMY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NIPMY has a market cap of 4B. Regarding current trading prices, ACOPF is priced at $6.75, while NIPMY trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NIPMY's P/E ratio is 20.39. In terms of profitability, ACOPF's ROE is +0.16%, compared to NIPMY's ROE of +0.06%. Regarding short-term risk, ACOPF and NIPMY have similar daily volatility (0.00).Check NIPMY's competition here
ACOPF vs NSLYF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NSLYF has a market cap of 4B. Regarding current trading prices, ACOPF is priced at $6.75, while NSLYF trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NSLYF's P/E ratio is 37.13. In terms of profitability, ACOPF's ROE is +0.16%, compared to NSLYF's ROE of +0.74%. Regarding short-term risk, ACOPF and NSLYF have similar daily volatility (0.00).Check NSLYF's competition here
ACOPF vs PIFMY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, PIFMY has a market cap of 3.6B. Regarding current trading prices, ACOPF is priced at $6.75, while PIFMY trades at $20.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas PIFMY's P/E ratio is 7.76. In terms of profitability, ACOPF's ROE is +0.16%, compared to PIFMY's ROE of +0.11%. Regarding short-term risk, ACOPF and PIFMY have similar daily volatility (0.00).Check PIFMY's competition here
ACOPF vs FPAFY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, FPAFY has a market cap of 3.6B. Regarding current trading prices, ACOPF is priced at $6.75, while FPAFY trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas FPAFY's P/E ratio is 4.99. In terms of profitability, ACOPF's ROE is +0.16%, compared to FPAFY's ROE of +0.17%. Regarding short-term risk, ACOPF is less volatile compared to FPAFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check FPAFY's competition here
ACOPF vs YMZBY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, YMZBY has a market cap of 3.6B. Regarding current trading prices, ACOPF is priced at $6.75, while YMZBY trades at $180.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas YMZBY's P/E ratio is 14.08. In terms of profitability, ACOPF's ROE is +0.16%, compared to YMZBY's ROE of +0.10%. Regarding short-term risk, ACOPF and YMZBY have similar daily volatility (0.00).Check YMZBY's competition here
ACOPF vs FPAFF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, FPAFF has a market cap of 3.5B. Regarding current trading prices, ACOPF is priced at $6.75, while FPAFF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas FPAFF's P/E ratio is 4.88. In terms of profitability, ACOPF's ROE is +0.16%, compared to FPAFF's ROE of +0.17%. Regarding short-term risk, ACOPF and FPAFF have similar daily volatility (0.00).Check FPAFF's competition here
ACOPF vs CRWKF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, CRWKF has a market cap of 3.4B. Regarding current trading prices, ACOPF is priced at $6.75, while CRWKF trades at $63.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas CRWKF's P/E ratio is 23.79. In terms of profitability, ACOPF's ROE is +0.16%, compared to CRWKF's ROE of +0.15%. Regarding short-term risk, ACOPF and CRWKF have similar daily volatility (0.00).Check CRWKF's competition here
ACOPF vs PRBZF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, PRBZF has a market cap of 3.4B. Regarding current trading prices, ACOPF is priced at $6.75, while PRBZF trades at $76.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas PRBZF's P/E ratio is 70.69. In terms of profitability, ACOPF's ROE is +0.16%, compared to PRBZF's ROE of +0.04%. Regarding short-term risk, ACOPF and PRBZF have similar daily volatility (0.00).Check PRBZF's competition here
ACOPF vs NSFMF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NSFMF has a market cap of 3.3B. Regarding current trading prices, ACOPF is priced at $6.75, while NSFMF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NSFMF's P/E ratio is 14.20. In terms of profitability, ACOPF's ROE is +0.16%, compared to NSFMF's ROE of +0.05%. Regarding short-term risk, ACOPF and NSFMF have similar daily volatility (0.00).Check NSFMF's competition here
ACOPF vs EBRPF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, EBRPF has a market cap of 3.3B. Regarding current trading prices, ACOPF is priced at $6.75, while EBRPF trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas EBRPF's P/E ratio is 14.19. In terms of profitability, ACOPF's ROE is +0.16%, compared to EBRPF's ROE of +0.09%. Regarding short-term risk, ACOPF and EBRPF have similar daily volatility (0.00).Check EBRPF's competition here
ACOPF vs TBLMF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TBLMF has a market cap of 3.2B. Regarding current trading prices, ACOPF is priced at $6.75, while TBLMF trades at $20.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TBLMF's P/E ratio is 12.97. In terms of profitability, ACOPF's ROE is +0.16%, compared to TBLMF's ROE of +0.21%. Regarding short-term risk, ACOPF and TBLMF have similar daily volatility (0.00).Check TBLMF's competition here
ACOPF vs LYSFF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, LYSFF has a market cap of 3.2B. Regarding current trading prices, ACOPF is priced at $6.75, while LYSFF trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas LYSFF's P/E ratio is 17.10. In terms of profitability, ACOPF's ROE is +0.16%, compared to LYSFF's ROE of +0.09%. Regarding short-term risk, ACOPF and LYSFF have similar daily volatility (0.00).Check LYSFF's competition here
ACOPF vs LYSFY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, LYSFY has a market cap of 3.1B. Regarding current trading prices, ACOPF is priced at $6.75, while LYSFY trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas LYSFY's P/E ratio is 16.94. In terms of profitability, ACOPF's ROE is +0.16%, compared to LYSFY's ROE of +0.09%. Regarding short-term risk, ACOPF and LYSFY have similar daily volatility (0.00).Check LYSFY's competition here
ACOPF vs NCHEY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NCHEY has a market cap of 3.1B. Regarding current trading prices, ACOPF is priced at $6.75, while NCHEY trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NCHEY's P/E ratio is 18.06. In terms of profitability, ACOPF's ROE is +0.16%, compared to NCHEY's ROE of +0.10%. Regarding short-term risk, ACOPF and NCHEY have similar daily volatility (0.00).Check NCHEY's competition here
ACOPF vs MRRTY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, MRRTY has a market cap of 2.9B. Regarding current trading prices, ACOPF is priced at $6.75, while MRRTY trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas MRRTY's P/E ratio is 11.03. In terms of profitability, ACOPF's ROE is +0.16%, compared to MRRTY's ROE of +0.82%. Regarding short-term risk, ACOPF is less volatile compared to MRRTY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check MRRTY's competition here
ACOPF vs FSRCY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, FSRCY has a market cap of 2.9B. Regarding current trading prices, ACOPF is priced at $6.75, while FSRCY trades at $184.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas FSRCY's P/E ratio is 9.81. In terms of profitability, ACOPF's ROE is +0.16%, compared to FSRCY's ROE of +0.21%. Regarding short-term risk, ACOPF and FSRCY have similar daily volatility (0.00).Check FSRCY's competition here
ACOPF vs CBCFF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, CBCFF has a market cap of 2.8B. Regarding current trading prices, ACOPF is priced at $6.75, while CBCFF trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas CBCFF's P/E ratio is 21.90. In terms of profitability, ACOPF's ROE is +0.16%, compared to CBCFF's ROE of +0.08%. Regarding short-term risk, ACOPF and CBCFF have similar daily volatility (0.00).Check CBCFF's competition here
ACOPF vs FTROF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, FTROF has a market cap of 2.8B. Regarding current trading prices, ACOPF is priced at $6.75, while FTROF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas FTROF's P/E ratio is 9.47. In terms of profitability, ACOPF's ROE is +0.16%, compared to FTROF's ROE of +0.21%. Regarding short-term risk, ACOPF and FTROF have similar daily volatility (0.00).Check FTROF's competition here
ACOPF vs EBRPY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, EBRPY has a market cap of 2.8B. Regarding current trading prices, ACOPF is priced at $6.75, while EBRPY trades at $17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas EBRPY's P/E ratio is 20.34. In terms of profitability, ACOPF's ROE is +0.16%, compared to EBRPY's ROE of +0.06%. Regarding short-term risk, ACOPF and EBRPY have similar daily volatility (0.00).Check EBRPY's competition here
ACOPF vs UVRBF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, UVRBF has a market cap of 2.5B. Regarding current trading prices, ACOPF is priced at $6.75, while UVRBF trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas UVRBF's P/E ratio is 11.80. In terms of profitability, ACOPF's ROE is +0.16%, compared to UVRBF's ROE of +0.10%. Regarding short-term risk, ACOPF and UVRBF have similar daily volatility (0.00).Check UVRBF's competition here
ACOPF vs MLFNF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, MLFNF has a market cap of 2.5B. Regarding current trading prices, ACOPF is priced at $6.75, while MLFNF trades at $20.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas MLFNF's P/E ratio is 17.70. In terms of profitability, ACOPF's ROE is +0.16%, compared to MLFNF's ROE of +0.13%. Regarding short-term risk, ACOPF and MLFNF have similar daily volatility (0.00).Check MLFNF's competition here
ACOPF vs TATYF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TATYF has a market cap of 2.4B. Regarding current trading prices, ACOPF is priced at $6.75, while TATYF trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TATYF's P/E ratio is 61.00. In terms of profitability, ACOPF's ROE is +0.16%, compared to TATYF's ROE of +0.02%. Regarding short-term risk, ACOPF and TATYF have similar daily volatility (0.00).Check TATYF's competition here
ACOPF vs CLBEY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, CLBEY has a market cap of 2.4B. Regarding current trading prices, ACOPF is priced at $6.75, while CLBEY trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas CLBEY's P/E ratio is 22.64. In terms of profitability, ACOPF's ROE is +0.16%, compared to CLBEY's ROE of +0.08%. Regarding short-term risk, ACOPF and CLBEY have similar daily volatility (0.00).Check CLBEY's competition here
ACOPF vs PRRFY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, PRRFY has a market cap of 2.4B. Regarding current trading prices, ACOPF is priced at $6.75, while PRRFY trades at $12.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas PRRFY's P/E ratio is 13.74. In terms of profitability, ACOPF's ROE is +0.16%, compared to PRRFY's ROE of +0.15%. Regarding short-term risk, ACOPF and PRRFY have similar daily volatility (0.00).Check PRRFY's competition here
ACOPF vs SUEZF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, SUEZF has a market cap of 2.4B. Regarding current trading prices, ACOPF is priced at $6.75, while SUEZF trades at $11.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas SUEZF's P/E ratio is -10.50. In terms of profitability, ACOPF's ROE is +0.16%, compared to SUEZF's ROE of -0.06%. Regarding short-term risk, ACOPF and SUEZF have similar daily volatility (0.00).Check SUEZF's competition here
ACOPF vs SUEZY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, SUEZY has a market cap of 2.3B. Regarding current trading prices, ACOPF is priced at $6.75, while SUEZY trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas SUEZY's P/E ratio is -10.27. In terms of profitability, ACOPF's ROE is +0.16%, compared to SUEZY's ROE of -0.06%. Regarding short-term risk, ACOPF and SUEZY have similar daily volatility (0.00).Check SUEZY's competition here
ACOPF vs NISUY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, NISUY has a market cap of 2.2B. Regarding current trading prices, ACOPF is priced at $6.75, while NISUY trades at $72.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas NISUY's P/E ratio is 12.71. In terms of profitability, ACOPF's ROE is +0.16%, compared to NISUY's ROE of +0.10%. Regarding short-term risk, ACOPF and NISUY have similar daily volatility (0.00).Check NISUY's competition here
ACOPF vs UVRBY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, UVRBY has a market cap of 2.2B. Regarding current trading prices, ACOPF is priced at $6.75, while UVRBY trades at $10.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas UVRBY's P/E ratio is 10.78. In terms of profitability, ACOPF's ROE is +0.16%, compared to UVRBY's ROE of +0.10%. Regarding short-term risk, ACOPF and UVRBY have similar daily volatility (0.00).Check UVRBY's competition here
ACOPF vs PFODF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, PFODF has a market cap of 2.1B. Regarding current trading prices, ACOPF is priced at $6.75, while PFODF trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas PFODF's P/E ratio is 12.40. In terms of profitability, ACOPF's ROE is +0.16%, compared to PFODF's ROE of +0.11%. Regarding short-term risk, ACOPF and PFODF have similar daily volatility (0.00).Check PFODF's competition here
ACOPF vs GRPBF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GRPBF has a market cap of 2.1B. Regarding current trading prices, ACOPF is priced at $6.75, while GRPBF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GRPBF's P/E ratio is N/A. In terms of profitability, ACOPF's ROE is +0.16%, compared to GRPBF's ROE of N/A. Regarding short-term risk, ACOPF and GRPBF have similar daily volatility (0.00).Check GRPBF's competition here
ACOPF vs ARZTF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, ARZTF has a market cap of 1.9B. Regarding current trading prices, ACOPF is priced at $6.75, while ARZTF trades at $62.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas ARZTF's P/E ratio is 522.33. In terms of profitability, ACOPF's ROE is +0.16%, compared to ARZTF's ROE of +0.23%. Regarding short-term risk, ACOPF and ARZTF have similar daily volatility (0.00).Check ARZTF's competition here
ACOPF vs TUFBY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TUFBY has a market cap of 1.8B. Regarding current trading prices, ACOPF is priced at $6.75, while TUFBY trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TUFBY's P/E ratio is 12.05. In terms of profitability, ACOPF's ROE is +0.16%, compared to TUFBY's ROE of +0.10%. Regarding short-term risk, ACOPF and TUFBY have similar daily volatility (0.00).Check TUFBY's competition here
ACOPF vs HOFJF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, HOFJF has a market cap of 1.8B. Regarding current trading prices, ACOPF is priced at $6.75, while HOFJF trades at $19.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas HOFJF's P/E ratio is 23.90. In terms of profitability, ACOPF's ROE is +0.16%, compared to HOFJF's ROE of +0.04%. Regarding short-term risk, ACOPF and HOFJF have similar daily volatility (0.00).Check HOFJF's competition here
ACOPF vs GNCGF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GNCGF has a market cap of 1.8B. Regarding current trading prices, ACOPF is priced at $6.75, while GNCGF trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GNCGF's P/E ratio is 24.00. In terms of profitability, ACOPF's ROE is +0.16%, compared to GNCGF's ROE of +0.12%. Regarding short-term risk, ACOPF and GNCGF have similar daily volatility (0.00).Check GNCGF's competition here
ACOPF vs TBLMY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TBLMY has a market cap of 1.7B. Regarding current trading prices, ACOPF is priced at $6.75, while TBLMY trades at $10.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TBLMY's P/E ratio is 12.02. In terms of profitability, ACOPF's ROE is +0.16%, compared to TBLMY's ROE of +0.17%. Regarding short-term risk, ACOPF and TBLMY have similar daily volatility (0.00).Check TBLMY's competition here
ACOPF vs AVSFY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, AVSFY has a market cap of 1.7B. Regarding current trading prices, ACOPF is priced at $6.75, while AVSFY trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas AVSFY's P/E ratio is 12.32. In terms of profitability, ACOPF's ROE is +0.16%, compared to AVSFY's ROE of +0.47%. Regarding short-term risk, ACOPF and AVSFY have similar daily volatility (0.00).Check AVSFY's competition here
ACOPF vs YNNHF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, YNNHF has a market cap of 1.6B. Regarding current trading prices, ACOPF is priced at $6.75, while YNNHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas YNNHF's P/E ratio is 15.45. In terms of profitability, ACOPF's ROE is +0.16%, compared to YNNHF's ROE of +0.16%. Regarding short-term risk, ACOPF and YNNHF have similar daily volatility (0.00).Check YNNHF's competition here
ACOPF vs GUZOF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GUZOF has a market cap of 1.6B. Regarding current trading prices, ACOPF is priced at $6.75, while GUZOF trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GUZOF's P/E ratio is 17.82. In terms of profitability, ACOPF's ROE is +0.16%, compared to GUZOF's ROE of +0.23%. Regarding short-term risk, ACOPF and GUZOF have similar daily volatility (0.00).Check GUZOF's competition here
ACOPF vs ARZTY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, ARZTY has a market cap of 1.6B. Regarding current trading prices, ACOPF is priced at $6.75, while ARZTY trades at $6.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas ARZTY's P/E ratio is 12.96. In terms of profitability, ACOPF's ROE is +0.16%, compared to ARZTY's ROE of +0.27%. Regarding short-term risk, ACOPF and ARZTY have similar daily volatility (0.00).Check ARZTY's competition here
ACOPF vs FNEVY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, FNEVY has a market cap of 1.5B. Regarding current trading prices, ACOPF is priced at $6.75, while FNEVY trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas FNEVY's P/E ratio is 13.00. In terms of profitability, ACOPF's ROE is +0.16%, compared to FNEVY's ROE of +0.05%. Regarding short-term risk, ACOPF and FNEVY have similar daily volatility (0.00).Check FNEVY's competition here
ACOPF vs FNEVF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, FNEVF has a market cap of 1.5B. Regarding current trading prices, ACOPF is priced at $6.75, while FNEVF trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas FNEVF's P/E ratio is 12.75. In terms of profitability, ACOPF's ROE is +0.16%, compared to FNEVF's ROE of +0.05%. Regarding short-term risk, ACOPF and FNEVF have similar daily volatility (0.00).Check FNEVF's competition here
ACOPF vs GNCGY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GNCGY has a market cap of 1.4B. Regarding current trading prices, ACOPF is priced at $6.75, while GNCGY trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GNCGY's P/E ratio is 18.84. In terms of profitability, ACOPF's ROE is +0.16%, compared to GNCGY's ROE of +0.12%. Regarding short-term risk, ACOPF and GNCGY have similar daily volatility (0.00).Check GNCGY's competition here
ACOPF vs HLFGY Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, HLFGY has a market cap of 1.4B. Regarding current trading prices, ACOPF is priced at $6.75, while HLFGY trades at $15.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas HLFGY's P/E ratio is 24.16. In terms of profitability, ACOPF's ROE is +0.16%, compared to HLFGY's ROE of +0.14%. Regarding short-term risk, ACOPF and HLFGY have similar daily volatility (0.00).Check HLFGY's competition here
ACOPF vs TUFUF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, TUFUF has a market cap of 1.1B. Regarding current trading prices, ACOPF is priced at $6.75, while TUFUF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas TUFUF's P/E ratio is 7.31. In terms of profitability, ACOPF's ROE is +0.16%, compared to TUFUF's ROE of +0.10%. Regarding short-term risk, ACOPF and TUFUF have similar daily volatility (0.00).Check TUFUF's competition here
ACOPF vs AKEJF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, AKEJF has a market cap of 1.1B. Regarding current trading prices, ACOPF is priced at $6.75, while AKEJF trades at $34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas AKEJF's P/E ratio is 16.59. In terms of profitability, ACOPF's ROE is +0.16%, compared to AKEJF's ROE of +0.05%. Regarding short-term risk, ACOPF and AKEJF have similar daily volatility (0.00).Check AKEJF's competition here
ACOPF vs JWLLF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, JWLLF has a market cap of 1.1B. Regarding current trading prices, ACOPF is priced at $6.75, while JWLLF trades at $25.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas JWLLF's P/E ratio is 24.38. In terms of profitability, ACOPF's ROE is +0.16%, compared to JWLLF's ROE of +0.13%. Regarding short-term risk, ACOPF and JWLLF have similar daily volatility (0.00).Check JWLLF's competition here
ACOPF vs GBFBF Comparison February 2026
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4.7B. In comparison, GBFBF has a market cap of 1.1B. Regarding current trading prices, ACOPF is priced at $6.75, while GBFBF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 38.44, whereas GBFBF's P/E ratio is 12.38. In terms of profitability, ACOPF's ROE is +0.16%, compared to GBFBF's ROE of N/A. Regarding short-term risk, ACOPF and GBFBF have similar daily volatility (0.00).Check GBFBF's competition here